Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • State News

    State News - Page 4

    Zydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate Injection

    Zydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate Injection

    Medical Dialogues Bureau6 Nov 2019 1:30 PM IST
    New Delhi: Cadila Healthcare on Tuesday said group firm Zydus Cadila has received final approval from the US health regulator for its generic version...
    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Medical Dialogues Bureau6 Nov 2019 1:26 PM IST
    Mumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Medical Dialogues Bureau6 Nov 2019 9:19 AM IST
    New Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

    Medical Dialogues Bureau5 Nov 2019 12:57 PM IST
    New Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Medical Dialogues Bureau5 Nov 2019 12:55 PM IST
    New Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
    Alleged carcinogenic impurity in Ranitidine: Dr Reddys Laboratories makes Rs 40-crore provisioning in PnL for market impact

    Alleged carcinogenic impurity in Ranitidine: Dr Reddy's Laboratories makes Rs 40-crore provisioning in PnL for market impact

    Medical Dialogues Bureau5 Nov 2019 12:52 PM IST
    Hyderabad: Dr Reddy's Laboratories, which initiated a voluntary recall of its Ranitidine from the US market following the ongoing investigation by the...
    SHOCKING: Pharmacist arrested for allegedly molesting woman inside medical store

    SHOCKING: Pharmacist arrested for allegedly molesting woman inside medical store

    Farhat Nasim2 Nov 2019 4:26 PM IST
    Bangalore: In a shocking incident, a city-based pharmacist has recently been arrested for allegedly molesting a woman inside the medical store,...
    Andhra Pradesh: Blast at Chemist shop, 2 dead

    Andhra Pradesh: Blast at Chemist shop, 2 dead

    Farhat Nasim2 Nov 2019 4:25 PM IST
    Though the cause of the fire is unknown, yet it is suspected that a blast in the AC compressor caused the incident. The cops found the dead body of...
    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent

    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent

    Medical Dialogues Bureau1 Nov 2019 3:29 PM IST
    Scale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Medical Dialogues Bureau1 Nov 2019 2:11 PM IST
    New Delhi: Drug firm Cadila Healthcare on Thursday said its Baddi facility in Himachal Pradesh has received establishment inspection report (EIR) from...
    Iconic Crocin Pain Relief to get a relaunch

    Iconic Crocin Pain Relief to get a relaunch

    Garima1 Nov 2019 1:49 PM IST
    GSK markets five varients of Crocin namely Crocin Advance, Crocin 650 Mg, Crocin Pain Relief, Crocin Cold & Flu and Crocin's Children Range...
    IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

    IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

    Medical Dialogues Bureau30 Oct 2019 2:11 PM IST
    Mumbai: IOL Chemicals and Pharmaceuticals (IOLCP) recently received a communication from US Food and Drug Administration (USFDA) with respect to an...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok